HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Binding of the ligand [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate receptor during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit.

Abstract
Binding of the ligand [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate (NMDA) receptor population on brain homogenates in rabbits was studied during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit. Homogenates were prepared from brain cortex, hippocampus and striatum. Hepatic encephalopathy was induced by a two-stage liver devascularization procedure and acute hyperammonemia by a prolonged ammonium-acetate infusion; rabbits receiving a sodium-potassium-acetate infusion served as controls. In these animal models extracellular brain glutamate levels are known to be elevated. However no significant alterations in the number nor the affinity of the MK-801 binding sites of the NMDA receptors were found during acute liver failure and acute hyperammonemia. These findings suggest that the NMDA receptor population remains unaltered in experimental encephalopathy from acute liver failure and acute hyperammonemia, despite alterations in extracellular brain glutamate levels.
AuthorsR J de Knegt, J Kornhuber, S W Schalm, K Rusche, P Riederer, J Tan
JournalMetabolic brain disease (Metab Brain Dis) Vol. 8 Issue 2 Pg. 81-94 (Jun 1993) ISSN: 0885-7490 [Print] United States
PMID8355641 (Publication Type: Journal Article)
Chemical References
  • Receptors, N-Methyl-D-Aspartate
  • Dizocilpine Maleate
  • Ammonia
Topics
  • Acute Disease
  • Ammonia (blood)
  • Animals
  • Binding Sites
  • Dizocilpine Maleate (metabolism)
  • Hepatic Encephalopathy (metabolism)
  • Liver Failure (metabolism)
  • Rabbits
  • Receptors, N-Methyl-D-Aspartate (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: